Description

From the makers of Azzalure The ready-to-use liquid formulation of Alluzience avoids any calculations and allows for more precision, meaning it has the potential to improve safety and dosing accuracy compared with powder form BoNT-A preparations. Each vial contains 125 Speywood units in 0.625 ml of solution. Alluzience is indicated for the temp
Show More

From the makers of Azzalure The ready-to-use liquid formulation of Alluzience avoids any calculations and allows for more precision, meaning it has the potential to improve safety and dosing accuracy compared with powder form BoNT-A preparations. Each vial contains 125 Speywood units in 0.625 ml of solution. Alluzience is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines seen at maximum frown in adult patients under 65 years As the first ready-to-use neurotoxin in Europe, Alluzience is fit for the needs of today; it will allow you to consistently optimize results and deliver patient satisfaction with more precision. Alluzience has been developed using novel production technologies meaning it is free from human and animal-derived proteins such as human serum albumin and lactose so less allergic reactions.
Less